Modified release formulations of a bupropion salt
First Claim
Patent Images
1. A modified release osmotic dosage form comprisinga core comprising bupropion hydrobromide;
- anda semipermeable membrane surrounding the core;
wherein the bupropion hydrobromide is present in a therapeutically effective amount, and wherein said dosage form releases the bupropion hydrobromide by dispensing the bupropion hydrobromide from the core via at least one passageway in the membrane by pressure created in the core by osmosis and/or by the expansion of a swellable material which forces the bupropion hydrobromide to be dispensed from core of the dosage form.
18 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
-
Citations
10 Claims
-
1. A modified release osmotic dosage form comprising
a core comprising bupropion hydrobromide; - and
a semipermeable membrane surrounding the core; wherein the bupropion hydrobromide is present in a therapeutically effective amount, and wherein said dosage form releases the bupropion hydrobromide by dispensing the bupropion hydrobromide from the core via at least one passageway in the membrane by pressure created in the core by osmosis and/or by the expansion of a swellable material which forces the bupropion hydrobromide to be dispensed from core of the dosage form. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10)
- and
Specification